Thy-1 (CD90) promotes bone formation and protects against obesity

Area of Science:

• Cell Biology
• Endocrinology
• Biomedical Science

Background:

• Osteoporosis and obesity stem from imbalanced osteogenic and adipogenic differentiation.
• Mesenchymal stem cells (MSCs) are crucial for bone and fat tissue development.
• Thy-1's regulatory role in fibroblasts suggests its involvement in MSC fate determination.

Purpose of the Study:

• To investigate the impact of Thy-1 expression on MSC differentiation towards osteogenesis and adipogenesis.
• To determine the in vivo consequences of Thy-1 deficiency on bone formation and adipose tissue development.
• To explore the relationship between serum Thy-1 concentrations and osteoporosis/obesity.

Main Methods:

• Comparison of MSC differentiation in Thy-1-deficient and wild-type mice.
• In vivo analysis of bone parameters (volume, formation rate, porosity, strength) and fat mass in Thy-1-deficient mice.
• Assessment of Wnt signaling pathway components (ligands, inhibitors) and serum Thy-1 levels.

Main Results:

• Thy-1-deficient MSCs showed reduced osteogenic and increased adipogenic differentiation.
• Thy-1-deficient mice exhibited decreased bone volume, lower bone formation rates, and reduced bone strength.
• Increased body weight, fat mass, and bone fat volume were observed in Thy-1-deficient mice, alongside altered Wnt signaling.
• Reduced serum Thy-1 concentrations correlated with osteoporosis and obesity.

Conclusions:

• Thy-1 plays a critical role in regulating the balance between osteogenic and adipogenic differentiation of MSCs.
• Thy-1 deficiency leads to impaired bone formation and increased adipose tissue accumulation, mirroring osteoporosis and obesity.
• Serum Thy-1 levels may serve as a biomarker for monitoring bone and fat metabolic dysregulation.